We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Amryt Pharma Plc | LSE:AMYT | London | Ordinary Share | GB00BKLTQ412 | ORD 6P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 143.00 | 151.00 | 170.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMAMYT
RNS Number : 2181T
Amryt Pharma PLC
11 October 2017
11 October 2017
AIM: AMYT
ESM: AYP
Amryt Pharma plc
("Amryt" or the "Company")
Director share purchases
Amryt, the biopharmaceutical company focused on rare and orphan diseases, is pleased to announce that, following approval of the Placing, it has received notification that Harry Stratford, Non-Executive Chairman, Joe Wiley, Chief Executive Officer, Rory Nealon, Chief Financial Officer and Chief Operating Officer, Markus Ziener and James Culverwell, Non-Executive Directors of the Company, acquired, in aggregate, 947,731 ordinary shares of 1p each ("Ordinary Shares"). The details of the purchases are as follows:
Hot Features
Premium
1. Details
of the person discharging managerial responsibilities
/ person closely associated
-------------- -----------------------------------------------------------------------
a) Name Harry Stratford
-------------- --------------------------------- ------------------------------------
2. Reason for the notification
-------------- -----------------------------------------------------------------------
a) Position / status Non-Executive Chairman
-------------- --------------------------------- ------------------------------------
b) Initial notification Initial notification
/ amendment
-------------- --------------------------------- ------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform,
auctioneer or auction monitor
-------------- -----------------------------------------------------------------------
a) Name Amryt Pharma plc
-------------- --------------------------------- ------------------------------------
b) Legal entity 213800BOS8WAJO2BEQ38
identifier
-------------- --------------------------------- ------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
-------------- -----------------------------------------------------------------------
a) Description of Ordinary shares of GBP0.01
the financial each
instrument, type
of instrument
Identification GB00BDD1LS57
code
-------------- --------------------------------- ------------------------------------
b) Nature of the Purchase of ordinary shares
transaction as part of placing announced
on 21 September 2017
-------------- --------------------------------- ------------------------------------
c) Currency British Pounds
-------------- --------------------------------- ------------------------------------
d) Price(s) and Price(s) Volume(s)
volume(s)
-------------- --------------------------------- ---------------- ---------------
GBP0.20 150,000
----------------------------------------------------------------- ---------------
e) Aggregated information
* Aggregated volume 150,000
GBP30,000
* Aggregated price
-------------- --------------------------------- ------------------------------------
f) Date of the transaction 11 October 2017
-------------- --------------------------------- ------------------------------------
g) Place of the London Stock Exchange,
transaction AIM
-------------- --------------------------------- ------------------------------------
1. Details
of the person discharging managerial responsibilities
/ person closely associated
-------------- -----------------------------------------------------------------------
a) Name Joe Wiley
-------------- --------------------------------- ------------------------------------
2. Reason for the notification
-------------- -----------------------------------------------------------------------
a) Position / status Director
-------------- --------------------------------- ------------------------------------
b) Initial notification Initial notification
/ amendment
-------------- --------------------------------- ------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform,
auctioneer or auction monitor
-------------- -----------------------------------------------------------------------
a) Name Amryt Pharma plc
-------------- --------------------------------- ------------------------------------
b) Legal entity 213800BOS8WAJO2BEQ38
identifier
-------------- --------------------------------- ------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
-------------- -----------------------------------------------------------------------
a) Description of Ordinary shares of GBP0.01
the financial each
instrument, type
of instrument
Identification GB00BDD1LS57
code
-------------- --------------------------------- ------------------------------------
b) Nature of the Purchase of ordinary shares
transaction as part of placing announced
on 21 September 2017
-------------- --------------------------------- ------------------------------------
c) Currency British Pounds
-------------- --------------------------------- ------------------------------------
d) Price(s) and Price(s) Volume(s)
volume(s)
-------------- --------------------------------- ---------------- ---------------
GBP0.20 221,592
----------------------------------------------------------------- ---------------
e) Aggregated information
* Aggregated volume 221,592
GBP44,318.40
* Aggregated price
-------------- --------------------------------- ------------------------------------
f) Date of the transaction 11 October 2017
-------------- --------------------------------- ------------------------------------
g) Place of the London Stock Exchange,
transaction AIM
-------------- --------------------------------- ------------------------------------
1. Details
of the person discharging managerial responsibilities
/ person closely associated
-------------- -----------------------------------------------------------------------
a) Name Rory Nealon
-------------- --------------------------------- ------------------------------------
2. Reason for the notification
-------------- -----------------------------------------------------------------------
a) Position / status Director
-------------- --------------------------------- ------------------------------------
b) Initial notification Initial notification
/ amendment
-------------- --------------------------------- ------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform,
auctioneer or auction monitor
-------------- -----------------------------------------------------------------------
a) Name Amryt Pharma plc
-------------- --------------------------------- ------------------------------------
b) Legal entity 213800BOS8WAJO2BEQ38
identifier
-------------- --------------------------------- ------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
-------------- -----------------------------------------------------------------------
a) Description of Ordinary shares of GBP0.01
the financial each
instrument, type
of instrument
Identification GB00BDD1LS57
code
-------------- --------------------------------- ------------------------------------
b) Nature of the Purchase of ordinary shares
transaction as part of placing announced
on 21 September 2017
-------------- --------------------------------- ------------------------------------
c) Currency British Pounds
-------------- --------------------------------- ------------------------------------
d) Price(s) and Price(s) Volume(s)
volume(s)
-------------- --------------------------------- ---------------- ---------------
GBP0.20 221,592
----------------------------------------------------------------- ---------------
e) Aggregated information
* Aggregated volume 221,592
GBP44,318.40
* Aggregated price
-------------- --------------------------------- ------------------------------------
f) Date of the transaction 11 October 2017
-------------- --------------------------------- ------------------------------------
g) Place of the London Stock Exchange,
transaction AIM
-------------- --------------------------------- ------------------------------------
1. Details
of the person discharging managerial
responsibilities / person closely associated
-------------- -------------------------------------------------------------------
a) Name James Culverwell
-------------- ----------------------------- ------------------------------------
2. Reason for the notification
-------------- -------------------------------------------------------------------
a) Position / status Non-Executive Director
-------------- ----------------------------- ------------------------------------
b) Initial notification Initial notification
/ amendment
-------------- ----------------------------- ------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform,
auctioneer or auction monitor
-------------- -------------------------------------------------------------------
a) Name Amryt Pharma plc
-------------- ----------------------------- ------------------------------------
b) Legal entity 213800BOS8WAJO2BEQ38
identifier
-------------- ----------------------------- ------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii)
each date; and (iv) each place where
transactions have been conducted
-------------- -------------------------------------------------------------------
a) Description of Ordinary shares of GBP0.01
the financial each
instrument, type
of instrument
Identification GB00BDD1LS57
code
-------------- ----------------------------- ------------------------------------
b) Nature of the Purchase of ordinary shares
transaction as part of placing announced
on 21 September 2017
-------------- ----------------------------- ------------------------------------
c) Currency British Pounds
-------------- ----------------------------- ------------------------------------
d) Price(s) and Price(s) Volume(s)
volume(s)
-------------- ----------------------------- ---------------- ---------------
GBP0.20 221,592
------------------------------------------------------------- ---------------
e) Aggregated information
* Aggregated volume 221,592
GBP44,318.40
* Aggregated price
-------------- ----------------------------- ------------------------------------
f) Date of the transaction 11 October 2017
-------------- ----------------------------- ------------------------------------
g) Place of the London Stock Exchange,
transaction AIM
-------------- ----------------------------- ------------------------------------
1. Details
of the person discharging managerial responsibilities
/ person closely associated
-------------- -----------------------------------------------------------------------
a) Name Marcus Ziener
-------------- --------------------------------- ------------------------------------
2. Reason for the notification
-------------- -----------------------------------------------------------------------
a) Position / status Non-Executive Director
-------------- --------------------------------- ------------------------------------
b) Initial notification Initial notification
/ amendment
-------------- --------------------------------- ------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform,
auctioneer or auction monitor
-------------- -----------------------------------------------------------------------
a) Name Amryt Pharma plc
-------------- --------------------------------- ------------------------------------
b) Legal entity 213800BOS8WAJO2BEQ38
identifier
-------------- --------------------------------- ------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
-------------- -----------------------------------------------------------------------
a) Description of Ordinary shares of GBP0.01
the financial each
instrument, type
of instrument
Identification GB00BDD1LS57
code
-------------- --------------------------------- ------------------------------------
b) Nature of the Purchase of ordinary shares
transaction as part of placing announced
on 21 September 2017
-------------- --------------------------------- ------------------------------------
c) Currency British Pounds
-------------- --------------------------------- ------------------------------------
d) Price(s) and Price(s) Volume(s)
volume(s)
-------------- --------------------------------- ---------------- ---------------
GBP0.20 132,955
----------------------------------------------------------------- ---------------
e) Aggregated information
* Aggregated volume 132,955
GBP26,591
* Aggregated price
-------------- --------------------------------- ------------------------------------
f) Date of the transaction 11 October 2017
-------------- --------------------------------- ------------------------------------
g) Place of the London Stock Exchange,
transaction AIM
-------------- --------------------------------- ------------------------------------
Enquiries:
C/o KTZ Communications
Amryt Pharma plc (details below)
Joe Wiley, CEO
Rory Nealon, CFO/COO
Shore Capital +44 (0) 20 7408 4090
Nomad, Joint Bookrunner
and Joint Broker
Edward Mansfield, Mark
Percy
WG Partners +44 (0) 20 3705 9321
Joint Bookrunner
Nigel Barnes, Nigel Birks,
Chris Lee
Davy +353 (1) 679 6363
ESM Adviser and Joint
Broker
John Frain, Anthony Farrell
Stifel +44 (0) 20 7710 7600
Joint Broker
Jonathan Senior, Ben Maddison
KTZ Communications +44 (0) 20 3178 6378
Katie Tzouliadis, Irene
Bermont-Penn, Emma Pearson
The company news service from the London Stock Exchange
END
DSHMMBTTMBBBBFR
(END) Dow Jones Newswires
October 11, 2017 02:00 ET (06:00 GMT)
1 Year Amryt Pharma Chart |
1 Month Amryt Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
